Washington, DC 20006-5349
HELPLINE
Arkadiusz Dudek, MD, PhD, discusses the Phase 2 Nivolumab (Opdivo) + Ramucirumab clinical trial for previously-treated mesothelioma patients. The study is available at Moffitt Cancer…
Dr. Paul Sugarbaker joins us for an interview about HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal mesothelioma. Paul Sugarbaker, MD, FACS, FRCS, is the Chief of…
Three mesothelioma patients shared their experiences with cancer-related cognitive impairment — also known as “chemo brain” — with Dr. Tracy Vannorsdall, a neuropsychologist at the…
For MesoTV, we brought back a valuable conversation about complementary vs alternative therapies from a previous conference on malignant mesothelioma in New York City. In…
In this video, Jane Churpek, MD, MS, discusses inherited genetics and mesothelioma, in particular as they relate to the BAP1 gene and the BRCA2. Specifically, she covers how…
Elliot Wakeam, MD, discussed mesothelioma treatment at the University of Michigan. Dr. Wakeam is a thoracic and lung transplant surgeon and assistant professor who uses…
Adnan Jaigirdar, MD, FACS, provides an overview of the U.S. Food and Drug Administration (FDA) expanded access program (compassionate use) for investigative therapies for mesothelioma patients. Dr. Jaigirdar is…
Five mesothelioma patients — Heather Von St. James, Rich Mosca, Liam Bradley, John Panza and Sara Babin — gathered for a community panel discussion on…
Charles Hesdorffer, MD discussed the immune system and its response to viral infections such as COVID-19, especially as it relates to mesothelioma patients. Dr. Hesdorffer…
Michael Becich, MD, PhD explains the background and purpose of the National Mesothelioma Virtual Tissue Bank (NMVB) — the only national tissue and data repository…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
